Computer-aided interpretation of dynamic magnetic resonance imaging reflects histopathology of invasive breast cancer

[1]  G. Brix,et al.  Simulation-based comparison of two approaches frequently used for dynamic contrast-enhanced MRI , 2010, European Radiology.

[2]  Mieczyslaw Gajda,et al.  Application of computer-aided diagnosis (CAD) in MR-mammography (MRM): do we really need whole lesion time curve distribution analysis? , 2009, Academic radiology.

[3]  S. Narod,et al.  Pattern of metastatic spread in triple-negative breast cancer , 2009, Breast Cancer Research and Treatment.

[4]  C. Sotiriou,et al.  Understanding the Molecular Basis of Histologic Grade , 2008, Pathobiology.

[5]  O. Nalcioglu,et al.  Estrogen receptor and breast MR imaging features: A correlation study , 2008, Journal of magnetic resonance imaging : JMRI.

[6]  W. Kaiser,et al.  Breast magnetic resonance imaging: principles and techniques. , 2007, Seminars in roentgenology.

[7]  F. Tresserra,et al.  Tumor Size and Lymph Node Status in Multifocal Breast Cancer , 2007, The breast journal.

[8]  Hanina Hibshoosh,et al.  Interobserver agreement and reproducibility in classification of invasive breast carcinoma: an NCI breast cancer family registry study , 2006, Modern Pathology.

[9]  成定 宏之.  Correlation between numeric gadolinium-enhanced dynamic MRI ratios and prognostic factors and histologic type of breast carcinoma , 2006 .

[10]  W. Kaiser,et al.  Potential MRI interpretation model: differentiation of benign from malignant breast masses. , 2005, AJR. American journal of roentgenology.

[11]  Joachim Boettcher,et al.  Further Signs in the Evaluation of Magnetic Resonance Mammography: A Retrospective Study , 2005, Investigative radiology.

[12]  N. Tunçbilek,et al.  Dynamic magnetic resonance imaging in determining histopathological prognostic factors of invasive breast cancers. , 2005, European journal of radiology.

[13]  Rebecca S Lewis,et al.  Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. , 2004, Radiology.

[14]  P. Levine,et al.  Histologic grade, stage, and survival in breast carcinoma , 2003, Cancer.

[15]  Tibor Tot,et al.  Invasive breast cancer: correlation of dynamic MR features with prognostic factors , 2003, European Radiology.

[16]  W. Kaiser,et al.  High grade and non-high grade ductal carcinoma in situ on dynamic MR mammography: characteristic findings for signal increase and morphological pattern of enhancement. , 2003, The British journal of radiology.

[17]  M. Knopp,et al.  Dynamic contrast‐enhanced MRI using Gd‐DTPA: Interindividual variability of the arterial input function and consequences for the assessment of kinetics in tumors , 2001, Magnetic resonance in medicine.

[18]  D Hahn,et al.  Understanding Why Contrast Enhancement in Dynamic MRI Is Not Reproducible: Illustration with a Simple Phantom , 2001, The breast journal.

[19]  Lindsay W. Turnbull,et al.  Dynamic Contrast Enhanced Magnetic Resonance Imaging of the Breast Is Superior to Triple Assessment for the Pre-Operative Detection of Multifocal Breast Cancer , 1999, Annals of Surgical Oncology.

[20]  A Horsman,et al.  Dynamic MR imaging of invasive breast cancer: correlation with tumour grade and other histological factors. , 1997, The British journal of radiology.

[21]  W. Donegan.  Tumor‐related prognostic factors for breast cancer , 1997, CA: a cancer journal for clinicians.

[22]  A. Schauer,et al.  Prognostic value of contrast-enhanced MR mammography in patients with breast cancer , 1997, European Radiology.

[23]  P Aspelin,et al.  Sensitivity and Specificity of MR Mammography with Histopathological Correlation in 250 Breasts , 1996, Acta radiologica.

[24]  S. Edge,et al.  Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features. , 1995, Radiology.

[25]  J. Marks,et al.  Overexpression of p53 and HER‐2/neu Proteins as Prognostic Markers in Early Stage Breast Cancer , 1994, Annals of surgery.

[26]  J. Folkman,et al.  Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. , 1991, The New England journal of medicine.

[27]  W. Kaiser,et al.  MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Preliminary observations. , 1989, Radiology.

[28]  C. Redmond,et al.  Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  S Friedman,et al.  The importance of histologic grade in long-term prognosis of breast cancer: a study of 1,010 patients, uniformly treated at the Institut Gustave-Roussy. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  R. Rubens,et al.  Steroid receptors and prognosis in operable (stage I and II) breast cancer. , 1983, European journal of cancer & clinical oncology.

[31]  J. Folkman.  Tumor angiogenesis: therapeutic implications. , 1971, The New England journal of medicine.

[32]  J Folkman,et al.  Transplacental carcinogenesis by stilbestrol. , 1971, The New England journal of medicine.